Antitrust & Trade Reg.
Apr. 28, 2026
Medtronic asks court to overturn $381.7M antitrust verdict
Medtronic seeks to overturn a $381.7 million antitrust verdict, arguing Applied Medical failed to prove monopoly power or anticompetitive conduct in a dispute over bundled medical device sales.
Medtronic Inc. continues to urge a California federal court to overturn a recent jury verdict or grant a new trial in its antitrust dispute with Applied Medical Resources Corp., contending the plaintiff's case "collapses as a matter of law" due to a lack of evidence of monopoly power over bundled products and de facto exclusive dealing.
At trial in February, a Los Angeles jury unanimously found Medtronic liable for monopolization and unreasonable restraint of trade, ...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In